Topefilgrastim Injection in the Treatment of High-Risk Pregnant Patients With Preeclampsia
Topefilgrastim Injection in the Treatment of High-Risk Pregnant Patients With Preeclampsia
Not yet recruiting · NCT07384936 · Registry updated 2026-02-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Topefilgrastim Injection in the Treatment of High-Risk Pregnant Patients With Preeclampsia | Female Urogenital Diseases and Pregnancy Complications, Urogenital Diseases, hypertension, pregnancy-induced, preeclampsia, pregnancy disorder | Not yet recruiting | Not applicable | 2026-02-03 | NCT07384936 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fang Wang | 2 |
| Xiamen Amoytop Biotech Co., Ltd. | 11 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Lanzhou University Second Hospital | Lanzhou | China | 4 |